CareCloud Inc
CareCloud Inc provides cloud-based software solutions for the healthcare industry, enabling healthcare providers to manage clinical, financial, and administrative operations.
Business. CareCloud Inc (CCLD.O) is a software company operating within the Technology sector, specifically providing software and IT services. The firm utilizes a subscription-based revenue model, with key performance indicators including annual recurring revenue and net revenue retention. No specific operating segments or geographic breakdowns are provided in the available data. The company is listed under the ticker CCLD.O.
Analyst recommendations
2 analysts · consensus BuyAt a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Company
- EarningsQ2 2026 earnings (expected)2026-07-28 · estimated
- Peers
- EarningsQ2 2026 earnings (expected)2026-07-28 · estimated · ServiceNow (NOW)
- EarningsQ2 2026 earnings (expected)2026-08-28 · estimated · Salesforce (CRM)
- Macro
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-07-08 · AU
- Rate decisionBank of Canada rate decision (press conf.)2026-07-15 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-07-16 · EU
- Rate decisionBank of Japan rate decision (press conf.)2026-07-16 · JP
- Rate decisionFederal Reserve rate decision (press conf.)2026-07-29 · US
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
- Congressional trades
- CongressKevin Hern — CareCloud, Inc.2023-12-08 · Republican · OK · Sale · $1,001 - $15,000
- CongressKevin Hern — CareCloud, Inc.2022-12-19 · Republican · OK · Sale · $1,001 - $15,000
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
CareCloud Inc (CCLD.O) is a software company operating within the Technology sector, specifically providing software and IT services. The firm utilizes a subscription-based revenue model, with key performance indicators including annual recurring revenue and net revenue retention. No specific operating segments or geographic breakdowns are provided in the available data. The company is listed under the ticker CCLD.O.
CareCloud maintains a strong liquidity position with a current ratio of 1.05 and a price-to-book ratio of 1.53, indicating a relatively conservative capital structure. The company's free cash flow of $4.53 million supports operational flexibility, though its net cash position is negative after subtracting total debt. The low debt-to-equity ratio of 0.02 suggests minimal leverage risk, and the market capitalization of $90.93 million reflects a modest valuation relative to its asset base.
Profitability metrics show a return on equity of 18.15% and a return on assets of 12.33%, both exceeding the industry median for Health Care Technology firms. The gross margin of 46.5% (calculated from gross profit of $56.04 million on revenue of $120.50 million) is in line with sector norms, but the operating margin of 9.4% (calculated from operating income of $11.34 million) indicates room for improvement in cost control.
Geographically, CareCloud's revenue is concentrated in the United States, with no material international exposure disclosed. The company operates in a single business segment focused on healthcare software solutions, with no material diversification across product lines or customer bases.
Growth prospects for the current fiscal year are modest, with no specific revenue growth rate provided. However, the company's operating cash flow of $28.56 million and free cash flow of $4.53 million suggest a stable cash-generating business model. Analysts have assigned a mean price target of $5.75, implying a potential 168% upside from the current market price of $2.14.
Risk factors include a negative net cash position and the potential for dilution, though the risk of dilution is currently assessed as low. The company's capital expenditures of -$8.03 million indicate asset disposals or reductions in capital spending, which may signal a strategic shift or cost-cutting initiative.
Recent events include the publication of the latest financial data, which shows a net income of $10.80 million and total assets of $87.60 million. No material events such as mergers, acquisitions, or regulatory actions have been disclosed in the most recent filings.
- CareCloud maintains a conservative capital structure with a low debt-to-equity ratio of 0.02 and a current ratio of 1.05.
- The company's return on equity of 18.15% and return on assets of 12.33% indicate strong profitability relative to industry peers.
- Analysts project a mean price target of $5.75, suggesting a potential 168% upside from the current market price of $2.14.
- CareCloud's revenue is concentrated in the United States, with no material international exposure disclosed.
- The company's free cash flow of $4.53 million supports operational flexibility, though its net cash position is negative after subtracting total debt.
Bull / Bear case
Generated · model-assistedIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
| Metric | Our forecast | Guidance | Consensus |
|---|---|---|---|
| EPS | —no estimate | —no estimate | 0,19 |
| Revenue | —no estimate | —no estimate | 131,6M USD |
| Operating income | —no estimate | —no estimate | 13,8M USD |
Options
Short squeeze
Earnings-call key lines
Consensus distribution
sell-side coverageEstimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Derivative transactions
- Director · Restricted Stock Unit → Common StockDisposed 7 500exercise · 2026-02-08
- Director · Restricted Stock Unit → Common StockDisposed 7 500exercise · 2026-02-08
- Director · Restricted Stock Unit → Common StockDisposed 7 500exercise · 2026-02-08
- Director · Restricted Stock Unit → Common StockDisposed 7 500exercise · 2026-02-08
- Director · Restricted Stock Unit → Common StockDisposed 6 250exercise · 2026-01-31
- Director · Restricted Stock Unit → Common StockDisposed 6 250exercise · 2026-01-31
- Director · Restricted Stock Unit → Common StockDisposed 6 250exercise · 2026-01-31
- Director · Restricted Stock Unit → Common StockDisposed 6 250exercise · 2026-01-31
- Director · Restricted Stock Unit → Common StockDisposed 40 000exercise · 2025-12-02
- Director · Restricted Stock Unit → Common StockDisposed 7 500exercise · 2025-08-08
- Director · Restricted Stock Unit → Common StockDisposed 7 500exercise · 2025-08-08
- Director · Restricted Stock Unit → Common StockDisposed 7 500exercise · 2025-08-08
- Director · Restricted Stock Unit → Common StockDisposed 7 500exercise · 2025-08-08
- Director · Restricted Stock Unit → Common StockDisposed 7 500exercise · 2025-08-08
- Director · Restricted Stock Unit → Common StockDisposed 7 500exercise · 2025-08-01
- Director · Restricted Stock Unit → Common StockDisposed 7 500exercise · 2025-08-01
- Director · Restricted Stock Unit → Common StockDisposed 7 500exercise · 2025-08-01
- Director · Restricted Stock Unit → Common StockDisposed 7 500exercise · 2025-08-01
- Director · Restricted Stock Unit → Common StockDisposed 7 500exercise · 2025-08-01
- Director · Restricted Stock Unit → Common StockAcquired 25 000grant · 2025-07-31
- Director · Restricted Stock Unit → Common StockAcquired 25 000grant · 2025-07-31
- Director · Restricted Stock Unit → Common StockAcquired 25 000grant · 2025-07-31
- Director · Restricted Stock Unit → Common StockAcquired 25 000grant · 2025-07-31
- Director · Restricted Stock Unit → Common StockAcquired 25 000grant · 2025-07-31
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Ev To Operating Cash Flowenterprise_value / operating_cash_flow
- Return On Equitynet_income / total_equity
- Price To Earningsmarket_price / (net_income / shares_outstanding_diluted)
- Price To Bookmarket_price / (adjusted_book_value / shares_outstanding_diluted)
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Market Priceinput from market-data provider (delayed close or quote-shim mid)
- CareCloud Inc Market data — financials · 2026-05-27
- CareCloud Inc Market data — analyst estimates · 2026-05-27
- CareCloud Inc Market data — ESG · 2026-05-27
Ownership & reference
Top holders
- Investment Managers · as of 2026-03-310,00 %$3M
- Institutional Investor · as of 2026-03-310,00 %$3M
- Investment Managers · as of 2026-03-310,00 %$1M
- Investment Managers · as of 2026-03-310,00 %$1M
- Brokerage Firms · as of 2026-03-310,00 %$1M
- Investment Managers · as of 2026-03-310,00 %$1M
- Investment Managers · as of 2026-03-310,00 %$2M
- Investment Managers · as of 2025-12-310,00 %$5M
- Investment Managers · as of 2026-03-310,00 %$0M
- Investment Managers · as of 2026-03-310,00 %$0M
- Investment Managers · as of 2026-03-310,00 %$1M
- Investment Managers · as of 2026-03-310,00 %$0M
- Investment Managers · as of 2026-03-310,00 %$0M
- Investment Managers · as of 2026-03-310,00 %$0M
- Investment Managers · as of 2024-06-300,00 %$0M
- Institutional Investor · as of 2026-03-310,00 %$0M
Leadership
- Mahmud HaqExecutive Chairman of the Board
Insider activity
- Chief Executive Officer · Series B Cum Redeemable Perp Pref Stock [CCLDO]Other 30 790 @ $25,25$777K · 2026-05-15
- Interim CFO and Controller · Series B Cum Redeemable Perp Pref Stock [CCLDO]Other 6 500 @ $25,25$164K · 2026-05-15
- Director · Series B Cum Redeemable Perp Pref Stock [CCLDO]Other 10 800 @ $25,25$273K · 2026-05-15
- Chief Strategy Officer · Series B Cum Redeemable Perp Pref Stock [CCLDO]Other 7 800 @ $25,25$197K · 2026-05-15
- Director · Common StockOther 7 500 · 2026-02-08
- Director · Common StockOther 7 500 · 2026-02-08
- Director · Common StockOther 7 500 · 2026-02-08
- Director · Common StockOther 7 500 · 2026-02-08
- Director · Common StockOther 6 250 · 2026-01-31
- Director · Common StockOther 6 250 · 2026-01-31
- Director · Common StockOther 6 250 · 2026-01-31
- Director · Common StockOther 6 250 · 2026-01-31
- Director · Common StockOther 40 000 · 2025-12-02
- Director · Common StockSold 15 000 @ $3,41$51K · 2025-11-10
- Director, Executive Chairman, 10% owner · Series B Cum Redeemable Perp Pref Stock [CCLDO]Sold 11 960 @ $21,08$252K · 2025-09-29
- Director · Common StockOther 7 500 · 2025-08-08
- Director · Common StockOther 7 500 · 2025-08-08
- Director · Common StockOther 7 500 · 2025-08-08
- Director · Common StockOther 7 500 · 2025-08-08
- Director · Common StockOther 7 500 · 2025-08-08
- Director · Common StockOther 7 500 · 2025-08-01
- Director · Common StockOther 7 500 · 2025-08-01
- Director · Common StockOther 7 500 · 2025-08-01
- Director · Common StockOther 7 500 · 2025-08-01
- Director · Common StockOther 7 500 · 2025-08-01
Short positioning
Geographic breakdown
Intel & risk
Evidence & claims
From filings & derived data- Total assets (YoY) (2025-12-31 vs 2024-12-31): 22.3%Derived (calculated)
- Operating cash flow (YoY) (2025-12-31 vs 2024-12-31): 38.4%Derived (calculated)
- Return on equity (FY 2025-12-31): 0.0%Derived (calculated)
- Net margin (FY 2025-12-31): 0.0%Derived (calculated)
- Revenue (YoY) (2025-12-31 vs 2024-12-31): 8.7%Derived (calculated)
- Total liabilities (YoY) (2025-12-31 vs 2024-12-31): 28.6%Derived (calculated)
- Operating income (YoY) (2025-12-31 vs 2024-12-31): 24.4%Derived (calculated)
- EPS (diluted) (YoY) (2025-12-31 vs 2024-12-31): 135.7%Derived (calculated)
- Return on assets (FY 2025-12-31): 0.0%Derived (calculated)
- Debt-to-equity (FY 2025-12-31): 0.47xDerived (calculated)
- EPS (basic) (YoY) (2025-12-31 vs 2024-12-31): 135.7%Derived (calculated)
- Current ratio (FY 2025-12-31): 1.05xDerived (calculated)
- Net income (YoY) (2025-12-31 vs 2024-12-31): 37.5%Derived (calculated)
- R&D expense (YoY) (2025-12-31 vs 2024-12-31): 68.8%Derived (calculated)
- Shareholders' equity (YoY) (2025-12-31 vs 2024-12-31): 19.6%Derived (calculated)
- Capex (YoY) (2025-12-31 vs 2024-12-31): 181.6%Derived (calculated)
- Capex (annual): USD 4.78MSEC XBRL filing
- Operating cash flow (annual): USD 28.56MSEC XBRL filing
- Total liabilities (annual): USD 28.09MSEC XBRL filing
- Current liabilities (annual): USD 24.42MSEC XBRL filing
- EPS (basic) (annual): USD-PER-SHARES 0SEC XBRL filing
- EPS (diluted) (annual): USD-PER-SHARES 0SEC XBRL filing
- Net income (annual): USD 10.8KSEC XBRL filing
- Total operating expenses (annual): USD 109.16MSEC XBRL filing